Category: Next-generation therapies
Precision Medicine The Rise of Targeted Cancer Therapies New cancer cases are expected to increase globally from Read Now 
Driving Innovation in Radiopharmaceutical Therapies Oncology clinical research is complex, demanding, and continually evolving. Bringing effective radiopharmaceutical therapies from proof-of-concept Read Now 
The Evolving Landscape of Oncology Drug Development Increasing incidence rates and the rise of novel therapies Oncology is the largest therapeutic area Read Now 
Developing Next-generation Therapies for Breast Cancer Patients Breast cancer is the second most common malignancy worldwide and the number one cancer in Read Now 
Helping to Develop Cell Therapies Catalyst Oncology is a specialty oncology CRO devoting time, energy, and capital to supporting biotechs Read Now 
Helping to Bring Antibody-drug Conjugates (ADCs) to Patients Purpose-built for ADC development Antibody-drug conjugates (ADCs) are transforming cancer care by combining precision antibody Read Now 
Helping to Bring Cancer Therapies to Patients Niche CRO with a difference Catalyst Oncology is a niche oncology CRO devoting time, energy, Read Now 
Helping to Bring Immunotherapies to Cancer Patients Catalyst Oncology is a specialty oncology clinical research organization (CRO) devoting time, energy, and capital Read Now 
Helping to Bring Hematologic Oncology Therapies to Cancer Patients Catalyst Oncology is a niche oncology clinical research organization (CRO) devoting time, energy, and capital Read Now 
Catalyst Clinical Research, Ledger Run Expand Strategic Partnership To Accelerate Research, Streamline Clinical Operations Catalyst Streamlines Business Processes with New Technologies Wilmington, NC and Tiburon, CA – 8 February Read Now